BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28697041)

  • 1. Circulating osteoprotegerin in postmenopausal osteoporotic women: marker of impaired glucose regulation or impaired bone metabolism.
    Mashavi M; Menaged M; Shargorodsky M
    Menopause; 2017 Nov; 24(11):1264-1268. PubMed ID: 28697041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study.
    Niu Y; Yang Z; Li X; Zhang W; Lu S; Zhang H; Chen X; Zhu L; Xing Y; Ning G; Qin L; Su Q
    BMC Endocr Disord; 2015 Dec; 15():75. PubMed ID: 26626139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
    Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study.
    Wu WT; Lee RP; Wang CH; Fang TC; Lin NT; Chen IH; Hsu BG
    J Womens Health (Larchmt); 2010 Apr; 19(4):785-90. PubMed ID: 20210559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women.
    Shargorodsky M; Boaz M; Luckish A; Matas Z; Gavish D; Mashavi M
    Atherosclerosis; 2009 Jun; 204(2):608-11. PubMed ID: 19062016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.
    Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance.
    O'Sullivan EP; Ashley DT; Davenport C; Penugonda L; Kelleher G; Devlin N; Crowley R; O'Shea P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
    Metabolism; 2013 Jan; 62(1):34-8. PubMed ID: 22841521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis.
    Grigorie D; Neacşu E; Marinescu M; Popa O
    Rom J Intern Med; 2003; 41(4):409-15. PubMed ID: 15526523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women.
    Dai Y; Shen L
    Chin Med J (Engl); 2007 Nov; 120(22):2017-21. PubMed ID: 18067789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?
    Lipovetzki Y; Zandman-Goddard G; Feldbrin Z; Shargorodsky M
    Immunol Res; 2017 Feb; 65(1):423-427. PubMed ID: 27503623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.
    Zhao HY; Liu JM; Ning G; Zhao YJ; Chen Y; Sun LH; Zhang LZ; Xu MY; Chen JL
    Osteoporos Int; 2008 Feb; 19(2):221-6. PubMed ID: 17703270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
    Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L
    Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
    D'Amore M; Fanelli M; D'Amore S; Fontana A; Minenna G
    Panminerva Med; 2006 Dec; 48(4):215-21. PubMed ID: 17215793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.
    Yano K; Tsuda E; Washida N; Kobayashi F; Goto M; Harada A; Ikeda K; Higashio K; Yamada Y
    J Bone Miner Res; 1999 Apr; 14(4):518-27. PubMed ID: 10234572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
    Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
    Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women.
    Ugur-Altun B; Altun A
    Arch Med Res; 2007 Nov; 38(8):891-6. PubMed ID: 17923273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.